Cigna Corporation

CI • Medical - Healthcare Plans

$306.60

— 0.00 (0.00%)

ResultadosÚltimo reporte: 30 jun 2026

PERFIL EQUILIBRADONeutralConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Perfil mixto. La empresa no es necesariamente mala, pero la valoración, el crecimiento o el balance todavía no justifican una señal más fuerte.

Capitalización

$80.93B

Crecimiento

—

Flujo de caja

5/5

Tendencia

Stable

Evidencia

Crecimiento positivo de ingresos · 19.0%Flujo de caja libre positivo · 31.54Flujo de caja libre consistente · 5/5Múltiplo de ganancias razonable · 12.29Nivel de deuda manejable · 0.75

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 5 ago 2026, 2:27 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$306.60

Change0.00%

Shares Out263.96M

Market Cap$80.93B

Enterprise Value$106.51B

52W Range239.51 - 315.47

Beta0.30

P/E12.61

P/S0.29

P/B1.90

P/FCF8.88

EV/Sales0.38

Price$306.60

Change0.00%

Shares Out263.96M

Market Cap$80.93B

Enterprise Value$106.51B

52W Range239.51 - 315.47

Beta0.30

P/E12.61

P/S0.29

P/B1.90

P/FCF8.88

EV/Sales0.38

EV/EBITDA11.98

EV/FCF11.69

Earnings Yield7.93%

FCF Yield11.26%

Dividend Yield1.50%

Gross Margin9.45%

Oper. Margin3.32%

Profit Margin2.17%

Debt/Eq0.75

Current Ratio0.85

Quick Ratio0.72

Target$342.08

Target Upside11.57%

Target Median$340.00

Target Range302.00 - 400.00

Volume1.86M

Avg Volume1.65M

EPS Surprise0.19

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

27/100

Fortaleza financiera

Deuda, caja, estabilidad

52/100

Potencial de crecimiento

Ingresos y expansión

95/100

Atractivo del precio

Barata o cara hoy

90/100

Por qué este puntaje▼

Crecimiento positivo de ingresos · 19.0%Flujo de caja libre positivo · 31.54Flujo de caja libre consistente · 5/5Múltiplo de ganancias razonable · 12.29Nivel de deuda manejable · 0.75Liquidez débil · 0.85

Analyst view

Analyst sentiment and price target

Analyst sentiment

Based on 39 analyst votes · 2026-10-20

86/100

Bullish

Hold

Bearish

Precio objetivo

2026-07-31

Bajo

$302.00

Promedio

$341.82

Mediana

$340.00

Alto

$400.00

Resumen de la compañía

IPO: 3/31/1982

Industria: Medical - Healthcare Plans

P/B i: 1.90

Deuda / Patrimonio i: 0.75

Margen operativo: 3.32%

Margen neto: 2.17%

ROE i: -

ROIC: -

Salud financiera

Puntaje10 / 20

Deuda / Patrimonio: 0.75

Ratio corriente: 0.85

Ratio rápido: 0.72

Estado: Moderate

Advertencias

Weak Liquidity
Weak quick ratio

Transacciones internas

Actividad reciente de ejecutivos e insiders

Perlberg Matthew

Transacción: 03/01/2027

OTRO

Cambio

+4,643

Precio

$287.55

Presentación

07/09/2026

Tipo

OTRO

Sadler Jason D

Transacción: 03/01/2027

OTRO

Cambio

+3,564

Precio

$287.55

Presentación

07/09/2026

Tipo

OTRO

Kautzner Adam

Transacción: 03/01/2027

OTRO

Cambio

+5,628

Precio

$287.55

Presentación

07/09/2026

Tipo

OTRO

Insider	Tipo	Cambio	Precio	Transacción	Presentación
Perlberg Matthew	OTRO	+4,643	$287.55	03/01/2027	07/09/2026
Sadler Jason D	OTRO	+3,564	$287.55	03/01/2027	07/09/2026
Kautzner Adam	OTRO	+5,628	$287.55	03/01/2027	07/09/2026
Holgerson Bryan	OTRO	+4,221	$287.55	03/01/2027	07/09/2026
Perlberg Matthew	OTRO	0	Not reported	07/01/2026	07/09/2026
Sanford Paul A	OTRO	0	Not reported	07/01/2026	07/09/2026
Sadler Jason D	OTRO	0	Not reported	07/01/2026	07/09/2026
Kautzner Adam	OTRO	0	Not reported	07/01/2026	07/09/2026
Holgerson Bryan	OTRO	—	Not reported	07/01/2026	07/09/2026
Holgerson Bryan	OTRO	0	Not reported	07/01/2026	07/09/2026
Perlberg Matthew	OTRO	+6,343	$305.86	03/01/2026	07/09/2026
Sadler Jason D	OTRO	+5,791	$305.86	03/01/2026	07/09/2026
Kautzner Adam	OTRO	+8,708	$305.86	03/01/2026	07/09/2026
Holgerson Bryan	OTRO	+4,790	$305.86	03/01/2026	07/09/2026
Perlberg Matthew	OTRO	+5,658	$336.48	03/01/2025	07/09/2026
Sadler Jason D	OTRO	+5,400	$336.48	03/01/2025	07/09/2026
Kautzner Adam	OTRO	+5,955	$336.48	03/01/2025	07/09/2026
Holgerson Bryan	OTRO	+2,978	$336.48	03/01/2025	07/09/2026
Perlberg Matthew	OTRO	+3,136	$294.61	03/01/2024	07/09/2026
Sadler Jason D	OTRO	+6,257	$294.61	03/01/2024	07/09/2026

Sobre la compañía

Cigna Corporation

Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.

Fuente - Link

Competidores

BDX CAH CNC COR CVS ELV HUM IDXX REGN ZTS

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Critical Review: Quest Diagnostics (NYSE:DGX) & Cigna Group (NYSE:CI)

Cigna Group (NYSE: CI - Get Free Report) and Quest Diagnostics (NYSE: DGX - Get Free Report) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability. Insider and Institutional Ownership 87.0% of Cigna

Defense World

A Look at The Cigna Group (CI) After 3.2% Gain -- GF Value $395.87 vs Price $298.81

On October 15, 2026, The Cigna Group (CI) shares rose 3.2% to $298.81, reflecting a positive momentum in the stock amidst a trading range of $239.51 to $311.34

GuruFocus

Under the Hood: Strong Demand, Higher Real Rates, and What It Means for Portfolios

Jobs Growth: Slower but Steady Over time, growth in real GDP roughly equals the combination of productivity growth and labor force growth, and employment growth tracks the labor force (exhibit 1). When the business cycle rolls over, recessions push unemployment higher, and then recoveries bring it back down.

ETF Trends

Here's Why Cigna (CI) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research

The Cigna Group's Third Quarter 2026 Earnings Release Details

BLOOMFIELD, Conn., Oct. 9, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its third quarter 2026 financial results on Thursday, November 5, 2026, and will host a conference call the same day.

PRNewsWire

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-04-30	7.6	7.79	0.19
2026-02-05	7.88	8.08	0.2
2025-10-30	7.64	7.83	0.19
2025-07-31	7.16	7.2	0.04
2025-05-02	6.35	6.74	0.39
2025-01-30	7.84	6.64	-1.2
2024-10-31	7.23	7.51	0.28
2024-08-01	6.41	6.72	0.31
2024-05-02	6.22	6.47	0.25
2024-02-02	6.54	6.79	0.25
2023-11-02	6.66	6.77	0.11
2023-08-03	6.02	6.13	0.11